Brief: SelectImmune Pharma Announces Patent Granted For IRF7 Inhibitors Case

Selectimmune Pharma AB

16/09/2020 07:35

Sept 16 (Reuters) - Selectimmune Pharma AB  SELECTb.TE :
    * SELECTIMMUNE PHARMA ANNOUNCES NEW PATENT GRANTED FOR IRF7
INHIBITORS CASE
    * DECISION TO GRANT ON EUROPEAN IRF7 INHIBITORS CASE BY
EUROPEAN
PATENT OFFICE (EPO)
    * EUROPEAN PATENT OFFICE (EPO) HAS GRANTED PATENT
APPLICATION AS
OF SEPTEMBER 16TH, 2020 FOR 38 EUROPEAN COUNTRIES

Source text for Eikon:  ID:nWkr9j41QY 
Further company coverage:  SELECTb.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))